Furthermore, larger amounts of adjacent normal breast tissue as well as of other precursor lesions, such as atypical ductal hyperplasia or lobular neoplasia, need also to be removed before carrying out the assay on invasive carcinoma, particularly if the tumor is ER/PR-negative. This evidence concerns the gene ESR1 and invasive carcinoma.